The U.S. Pharmaceutical Management Bureau approves a specific population to vaccinate and upgraded version of Modner and Pfizer vaccine

In a statement, the U.S. Pharmaceutical Management Bureau said that the upgraded version of the vaccine is a binary vaccine, which can be used for the new subtype BA.4 and BA.5 spiny protein of the new crown virus strains and the new crown virus Omikon mutant strains.effect.

According to the US Pharmaceutical Management Bureau, the public can inoculate the upgraded version of Modner or Pfizer vaccine as a single agent after completing the initial vaccination or enhanced needle vaccination for at least two months.The upgraded version of Modner vaccine is suitable for people 18 and above, and the upgraded version of Pfizer vaccine is suitable for people 12 and above.

According to the US Pharmaceutical Administration, the new subtype of BA.4 and BA.5 is currently the dominant strain in the United States. It is expected that these two new subtypes will continue to spread in the fall and winter of this year.

In the statement, the director of the US Pharmaceutical Administration Robert Carlyv said that the public interior activity time of the public will increase after entering the autumn. It is strongly recommended that the eligible public vaccination and upgrade vaccine will be strongly recommended to better resist the current popular mutant strains.

- END -